Antibody-labelled gold nanoparticles synthesized by laser ablation to detect SARS-CoV-2 antigen spike
Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radi...
Saved in:
Published in | ADMET & DMPK Vol. 12; no. 1; pp. 193 - 208 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article Paper |
Language | English |
Published |
Croatia
Međunarodna udruga fizikalnih kemičara
01.01.2024
International Association of Physical Chemists International Association of Physical Chemists (IAPC) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.
The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.
The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.
In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2. |
---|---|
AbstractList | Background and purpose
Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.
Experimental approach
The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.
Key results
The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.
Conclusion
In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2. Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2. Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.Background and purposeRapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.Experimental approachThe AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.Key resultsThe size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.ConclusionIn this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2. Background and purpose: Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. Experimental approach: The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. Key results: The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. Conclusion: In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2. |
Author | Isnaeni, Isnaeni Sopandi, Vidhia Tiara Annisa, Annisa Pambudi, Sabar Suryanggono, Jodi Sulfianti, Asri El Muttaqien, Sjaikhurrizal Widayanti, Tika Ningsih, Febby Nurdiya Mardliyati, Etik |
AuthorAffiliation | 3 Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN) , Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia 2 Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University , Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia 1 Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN) , LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia |
AuthorAffiliation_xml | – name: 1 Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN) , LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – name: 3 Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN) , Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia – name: 2 Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University , Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia |
Author_xml | – sequence: 1 givenname: Asri surname: Sulfianti fullname: Sulfianti, Asri organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 2 givenname: Vidhia Tiara surname: Sopandi fullname: Sopandi, Vidhia Tiara organization: Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University, Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia – sequence: 3 givenname: Isnaeni surname: Isnaeni fullname: Isnaeni, Isnaeni organization: Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN), Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia – sequence: 4 givenname: Jodi surname: Suryanggono fullname: Suryanggono, Jodi organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 5 givenname: Sabar surname: Pambudi fullname: Pambudi, Sabar organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 6 givenname: Sjaikhurrizal surname: El Muttaqien fullname: El Muttaqien, Sjaikhurrizal organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 7 givenname: Febby Nurdiya surname: Ningsih fullname: Ningsih, Febby Nurdiya organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 8 givenname: Tika surname: Widayanti fullname: Widayanti, Tika organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 9 givenname: Etik surname: Mardliyati fullname: Mardliyati, Etik organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia – sequence: 10 givenname: Annisa surname: Annisa fullname: Annisa, Annisa organization: Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University, Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38560711$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1vEzEQhi1UREvphR-AfOSyxV57_XFCUVSgUiUkClytsT2bbLuxw9pBCr-ehQTUnGY07zvPzGhekrOUExLymrPrrrP2HcQN1uuWafuMXHAjTaM1N2dP8nNyVcoDY4xrKxizL8i5MJ1imvMLgotUB5_jvhnB4zhipKs8Rpog5S1MdQgjFlr2qa6xDL9m2e_pCAUnCn6EOuREa6YRK4ZK7xdf7ptl_t60FGbuChMt2-ERX5HnPYwFr47xknz7cPN1-am5-_zxdrm4a6Jkuja9tcAQmTIRRQum49hzZY2FTvEAkbVeBq_6CL0GGb3ogpoNRrWedQqEuCS3B27M8OC207CBae8yDO5vIU8rd7zJsd6D7o2OrVXSGm84t15rxjoZmOz9zHp_YG13foMxYKoTjCfQUyUNa7fKPx1nVkvD7UxoDoT1FODxpPNQKVPAOXWCS8XU7H97nDjlHzss1W2GEuanQMK8K04wwbmQvPtjffN0uf_sf48VvwF3iqjp |
ContentType | Journal Article Paper |
Copyright | Copyright © 2024 by the authors. Copyright © 2024 by the authors. 2024 |
Copyright_xml | – notice: Copyright © 2024 by the authors. – notice: Copyright © 2024 by the authors. 2024 |
DBID | NPM 7X8 VP8 5PM DOA |
DOI | 10.5599/admet.2079 |
DatabaseName | PubMed MEDLINE - Academic Portal of Croatian Scientific and Professional Journals – HRČAK PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1848-7718 |
EndPage | 208 |
ExternalDocumentID | oai_doaj_org_article_0fba7f87d296498b8119b770054c04fb PMC10974819 oai_hrcak_srce_hr_314606 38560711 |
Genre | Journal Article |
GroupedDBID | ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV GROUPED_DOAJ M~E NPM OK1 PGMZT RPM VP8 7X8 5PM |
ID | FETCH-LOGICAL-d407t-f99a0ee068de32a851ef16989a561cad02b4cb6fdaf7a4db35c6f16862b056a33 |
IEDL.DBID | DOA |
ISSN | 1848-7718 |
IngestDate | Wed Aug 27 01:20:41 EDT 2025 Thu Aug 21 18:35:04 EDT 2025 Tue Feb 27 04:16:25 EST 2024 Fri Jul 11 03:25:08 EDT 2025 Thu Jan 02 22:36:43 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Covid-19 monoclonal antibody lateral flow immunoassay anti-SARS-CoV-2 |
Language | English |
License | Copyright © 2024 by the authors. cc-by: openAccess This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d407t-f99a0ee068de32a851ef16989a561cad02b4cb6fdaf7a4db35c6f16862b056a33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 314606 |
OpenAccessLink | https://doaj.org/article/0fba7f87d296498b8119b770054c04fb |
PMID | 38560711 |
PQID | 3031134156 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0fba7f87d296498b8119b770054c04fb pubmedcentral_primary_oai_pubmedcentral_nih_gov_10974819 hrcak_primary_oai_hrcak_srce_hr_314606 proquest_miscellaneous_3031134156 pubmed_primary_38560711 |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Croatia |
PublicationPlace_xml | – name: Croatia |
PublicationTitle | ADMET & DMPK |
PublicationTitleAlternate | ADMET DMPK |
PublicationYear | 2024 |
Publisher | Međunarodna udruga fizikalnih kemičara International Association of Physical Chemists International Association of Physical Chemists (IAPC) |
Publisher_xml | – name: Međunarodna udruga fizikalnih kemičara – name: International Association of Physical Chemists – name: International Association of Physical Chemists (IAPC) |
SSID | ssj0001793009 |
Score | 2.2498975 |
Snippet | Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2... Background and purpose Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome... Background and purpose: Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome... |
SourceID | doaj pubmedcentral hrcak proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 193 |
SubjectTerms | anti-SARS-CoV-2 Covid-19 lateral flow immunoassay monoclonal antibodies monoclonal antibody Original Scientific Paper |
Title | Antibody-labelled gold nanoparticles synthesized by laser ablation to detect SARS-CoV-2 antigen spike |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38560711 https://www.proquest.com/docview/3031134156 https://hrcak.srce.hr/314606 https://pubmed.ncbi.nlm.nih.gov/PMC10974819 https://doaj.org/article/0fba7f87d296498b8119b770054c04fb |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQ3ywflZHQnmrVie3EOZaKqkICVbRFvUXjeEJXLUm12R7Cr2cmXuguQuLCLXIsO_Zz7GfP-I0Q70q0sXHglXPeKBswKtBYKtdqyCs0BVq-jfzpc3F8bj9euIuNUF_sE5bkgVPH7es2QNn6MrJ9sPLBZ1kVypKpRqNtG3j2pTVvYzM1na7QsCP2kPRIWVRrH-J3ZN_JyWeLayE2erls4Opv1PJPD8mNJefooXiw5oryIH3jI3EPu8difpLEpsc9eXZ3d2rYk3N5cidDPT4RHANhEfo4KgKaj-ej_NZfR9lBRxvltT-cHMaOKOCw-EGvwyiJS-NSQkgecnLVy4hsZpCnB19O1WH_VeWSsGAJTzncLK7wqTg_-nB2eKzWQRVUpL3bSrVVRWCgLnxEkwMRLmwzjiIJxKQaiDoPtglFG6EtwcZgXFNQBtr4BOJKYMwzsdP1Hb4QktZXbJypYhGMzbGC6HNAr40LufdOz8R77uj6Julm1KxkPSUQvvW6nfW_8J2J-QTTVikpZVg2SI-1odleFzPx9heONf0ibPeADvvboaZVOmPdOkd5nidcf5dmvGOFvWwm_BbiW9Vtv-kWl5MMN9vuLRGql_-jma_E_ZzoUjrceS12VstbfEN0ZxV2p5G9O51D_QQcfgNB |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibody-labelled+gold+nanoparticles+synthesized+by+laser+ablation+to+detect+SARS-CoV-2+antigen+spike&rft.jtitle=ADMET+%26+DMPK&rft.au=Sulfianti%2C+Asri&rft.au=Sopandi%2C+Vidhia+Tiara&rft.au=Isnaeni%2C+Isnaeni&rft.au=Suryanggono%2C+Jodi&rft.date=2024-01-01&rft.issn=1848-7718&rft.eissn=1848-7718&rft.volume=12&rft.issue=1&rft.spage=193&rft_id=info:doi/10.5599%2Fadmet.2079&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1848-7718&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1848-7718&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1848-7718&client=summon |